(Q35602660)

9 August 2017

1 reference

title

Emerging drugs in migraine treatment (English)

1 reference

9 August 2017

Christian Waeber

1

0 references

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Expert Opinion on Emerging Drugs

9 August 2017

published in

1 reference

9 August 2017

volume

8

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

437-456

1 reference

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The impact of drug therapy on quality of life in headache and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Burden of migraine in the United States: disability and economic costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The pharmacology of current anti-migraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Fluoxetine prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Flunarizine in migraine prophylaxis: an Indian trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Aspirin prophylaxis in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Successful migraine prophylaxis with naproxen sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Methysergide in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Topiramate in migraine prevention: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

New migraine preventive options: an update with pathophysiological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Possible mechanisms of valproate in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Costs and outcomes of early versus delayed migraine treatment with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

NMDA channel regulation by channel-associated protein tyrosine kinase Src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

A P2X purinoceptor expressed by a subset of sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Platelet nitric oxide metabolites in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The role of nitric oxide in nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Transcranial magnetic stimulation of visual area V5 in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Functional MRI-BOLD of visually triggered headache in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Role of calcium channels in spreading depression in rat hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

CGRP may play a causative role in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

New therapeutic target in primary headaches - blocking theCGRP receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Novel anticonvulsant medications in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Interleukin-1beta-induced substance P release from rat cultured primary afferent neurons driven by two phospholipase A2 enzymes: secretory type IIA and cytosolic type IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Migraine: a platelet disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Nuclear factor-kappaB as a molecular target for migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Induction of calcium-dependent nitric oxide synthases by sex hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Estradiol-17 beta and mu-opioid peptides rapidly hyperpolarize GnRH neurons: a cellular mechanism of negative feedback?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Electrophysiological and cellular effects of estrogen on neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Sigma1 receptor modulation of opioid analgesia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

A Placebo-Controlled, Double-Blind, Cross-Over Trial of Flunarizine in Common Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

AMPA receptor–PDZ interactions in facilitation of spinal sensory synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.437

21 January 2018

Identifiers

DOI

10.1517/14728214.8.2.437

1 reference

release_xzgtntsx6zeefa3y33phq56bdu

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xzgtntsx6zeefa3y33phq56bdu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference